BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8019431)

  • 1. The interactions of modified lipoproteins with human erythrocyte membranes.
    Jóźwiak Z; Pałecz D; Bartosz G
    Biochem Mol Biol Int; 1994 Feb; 32(2):259-67. PubMed ID: 8019431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship of chemical modification of membrane proteins and plasma lipoproteins to reduced membrane fluidity of erythrocytes from diabetic subjects.
    Watala C; Winocour PD
    Eur J Clin Chem Clin Biochem; 1992 Sep; 30(9):513-9. PubMed ID: 1457612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluidity alterations induced by chemical modification of erythrocyte membrane proteins.
    Jóźwiak Z; Schön W; Kraft G; Gärtner H
    Biochem Int; 1992 Oct; 28(2):265-72. PubMed ID: 1333768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased susceptibility to lipid oxidation of low-density lipoproteins and erythrocyte membranes from diabetic patients.
    Rabini RA; Fumelli P; Galassi R; Dousset N; Taus M; Ferretti G; Mazzanti L; Curatola G; Solera ML; Valdiguié P
    Metabolism; 1994 Dec; 43(12):1470-4. PubMed ID: 7990698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet activation by oxidatively modified low density lipoproteins.
    Ardlie NG; Selley ML; Simons LA
    Atherosclerosis; 1989 Apr; 76(2-3):117-24. PubMed ID: 2730708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electron paramagnetic resonance study of lipid and protein membrane components of erythrocytes oxidized with hydrogen peroxide.
    Mendanha SA; Anjos JL; Silva AH; Alonso A
    Braz J Med Biol Res; 2012 Jun; 45(6):473-81. PubMed ID: 22473321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of genistein and daidzein on erythrocyte membrane fluidity: an electron paramagnetic resonance study.
    Ajdzanović V; Spasojević I; Filipović B; Sosić-Jurjević B; Sekulić M; Milosević V
    Can J Physiol Pharmacol; 2010 Apr; 88(4):497-500. PubMed ID: 20555419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The erythrocyte membrane structure in patients with mixed hyperlipidemia].
    Broncel M; Balcerak M; Bała A; Koter-Michalak M; Duchnowicz P; Chojnowska-Jezierska J
    Wiad Lek; 2007; 60(1-2):4-9. PubMed ID: 17607961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free radical lipid oxidation affects cholesterol transfer between lipoproteins and erythrocytes.
    Azizova OA; Panasenko OM; Vol'nova TV; Vladimirov YA
    Free Radic Biol Med; 1989; 7(3):251-7. PubMed ID: 2550331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cholesterol-acceptor properties of high-density lipoproteins with respect to erythrocyte membranes in patients with ischemic heart disease].
    Torkhovskaia TI; Gorbatenkova EA; Dudaev VA; Chesnokova IaM; Azizova OA
    Vopr Med Khim; 1986; 32(2):101-5. PubMed ID: 3010565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of plasma lipoproteins with erythrocytes. I. Alteration of erythrocyte morphology.
    Hui DY; Harmony JA
    Biochim Biophys Acta; 1979 Feb; 550(3):407-24. PubMed ID: 217429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower levels of erythrocyte membrane fluidity in diabetic patients. A spin label study.
    Kamada T; Otsuji S
    Diabetes; 1983 Jul; 32(7):585-91. PubMed ID: 6305749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrocyte spectrin alteration induced by low-density lipoprotein.
    Hui DY; Harmony JA
    J Supramol Struct; 1979; 10(2):253-63. PubMed ID: 222969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of oxidized low-density lipoprotein in human serum by NMR spectroscopy.
    Jankowski J; Nofer JR; Tepel M; Griewel B; Schlüter H; Assmann G; Zidek W
    Clin Sci (Lond); 1998 Oct; 95(4):489-95. PubMed ID: 9748425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDL oxidability and its protective effect against LDL oxidation in Type 2 diabetic patients.
    Sanguinetti SM; Brites FD; Fasulo V; Verona J; Elbert A; Wikinski RL; Schreier LE
    Diabetes Nutr Metab; 2001 Feb; 14(1):27-36. PubMed ID: 11345163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of the plasma lipoprotein spectrum on the cholesterol level in erythrocyte membranes].
    Torkhovskaia TI; Khalilov EM; Fortinskaia ES; Kliuchnikova ZhI; Ryzhkova LK
    Vopr Med Khim; 1985; 31(4):83-7. PubMed ID: 4049793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia.
    Koter M; Broncel M; Chojnowska-Jezierska J; Klikczynska K; Franiak I
    Eur J Clin Pharmacol; 2002 Nov; 58(8):501-6. PubMed ID: 12451426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of oxidized low density lipoproteins on the structure of platelet membrane. Use of electron paramagnetic resonance].
    Vlasova II
    Biofizika; 1999; 44(2):272-80. PubMed ID: 10418677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of daunorubicin and glutaraldehyde treatment on the structure of erythrocyte membrane.
    Szwarocka A; Jóźwiak Z
    Int J Pharm; 1999 Apr; 181(1):117-23. PubMed ID: 10370208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in the surface charge of plasma lipoproteins during their auto-oxidation].
    Panasenko OM; Azizova OA; Borin ML; Arnol'd K
    Biull Eksp Biol Med; 1986 Jan; 101(1):24-6. PubMed ID: 3002515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.